This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
M Brensilver , KG Heinzerling , AN Swanson , D Telesca , BA Furst , SJ Shoptaw (2013) Cigarette smoking as a target for potentiating outcomes for methamphetamine abuse treatment. Drug Alcohol Rev 32:96–99.
CC Cruickshank , KR Dyer (2009) A review of the clinical pharmacology of methamphetamine. Addiction 104:1085–1099.
R De La Garza II, JJ Mahoney III, C Culbertson , S Shoptaw , TF Newton (2008a) The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers. Pharmacol, Biochem, Behav 89:200–208.
R De La Garza , S Shoptaw , TF Newton (2008b) Evaluation of the cardiovascular and subjective effects of rivastigmine in combination with methamphetamine in methamphetamine-dependent human volunteers. Int J Neuropsychopharmacol 11:729–741.
R De La Garza II, T Zorick , ED London , TF Newton (2010) Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers. Drug and Alcohol Depend 106:173–180.
R De La Garza II, TF Newton , CN Haile , JH Yoon , CS Nerumalla , JJ Mahoney III, A Aziziyeh (2012) Rivastigmine reduces “likely to use methamphetamine” in methamphetamine-dependent volunteers. Prog Neuropsychopharmacol Biol Psychiatry 37:141–146.
LK Dobbs , GP Mark (2008) Comparison of systemic and local methamphetamine treatment on acetylcholine and dopamine levels in the ventral tegmental area in the mouse. Neuroscience 156:700–711.
LK Dobbs , GP Mark (2012) Acetylcholine from the mesopontine tegmental nuclei differentially affects methamphetamine induced locomotor activity and neurotransmitter levels in the mesolimbic pathway. Behav Brain Res 226:224–234.
AM Elkashef , RA Rawson , AL Anderson , SH Li , T Holmes , EV Smith (2008) Bupropion for the treatment of methamphetamine dependence. Neuropsychopharmacology 33:1162–1170.
MW Fischman , RW Foltin (1991) Utility of subjective-effects measurements in assessing abuse liability of drugs in humans. Br J Addict 86:1563–1570.
T Franklin , Z Wang , JJ Suh , R Hazan , J Cruz , Y Li (2011) Effects of varenicline on smoking cue-triggered neural and craving responses. Arch Gen Psychiatry 68:516–526.
AA Grace , SB Floresco , Y Goto , DJ Lodge (2007) Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci 30:220–227.
M Haney , ED Collins , AS Ward , RW Foltin , MW Fischman (1999) Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans. Psychopharmacology 143:102–110.
CL Hart , AS Ward , M Haney , RW Foltin , MW Fischman (2001) Methamphetamine self-administration by humans. Psychopharmacology 157:75–81.
CL Hart , M Haney , SK Vosburg , E Rubin , RW Foltin (2008) Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology 33:761–768.
T Hiranita , Y Nawata , K Sakimura , K Anggadiredja , T Yamamoto (2006) Suppression of methamphetamine-seeking behavior by nicotinic agonists. Proc Natl Acad Sci U S A 103:8523–8527.
T Hiranita , Y Nawata , K Sakimura , T Yamamoto (2008) Methamphetamine-seeking behavior is due to inhibition of nicotinic cholinergic transmission by activation of cannabinoid CB1 receptors. Neuropharmacology 55:1300–1306.
SJ Kish , KS Kalasinsky , Y Furukawa , M Guttman , L Ang , L Li (1999) Brain choline acetyltransferase activity in chronic, human users of cocaine, methamphetamine, and heroin. Mol Psychiatry 4:26–32.
NK Lee , RA Rawson (2008) A systematic review of cognitive and behavioural therapies for methamphetamine dependence. Drug Alcohol Rev 27:309–317.
M Longo , W Wickes , M Smout , S Harrison , S Cahill , JM White (2010) Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence. Addiction 105:146–154.
M Mameli-Engvall , A Evrard , S Pons , U Maskos , TH Svensson , JP Changeux (2006) Hierarchical control of dopamine neuron-firing patterns by nicotinic receptors. Neuron 50:911–921.
MC McElhiney , JG Rabkin , R Rabkin , EV Nunes (2009) Provigil (modafinil) plus cognitive behavioral therapy for methamphetamine use in HIV+ gay men: a pilot study. Am J Drug Alcohol Abuse 35:34–37.
C McGregor , M Srisurapanont , A Mitchell , W Wickes , JM White (2008) Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: a comparison of mirtazapine and modafinil with treatment as usual. J Subst Abuse Treat 35:334–342.
TF Newton , JD Roache , R De La Garza II, T Fong , CL Wallace , SH Li (2005) Safety of intravenous methamphetamine administration during treatment with bupropion. Psychopharmacology 182:426–435.
TF Newton , JD Roache , R De La Garza II, T Fong , CL Wallace , SH Li (2006) Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. Neuropsychopharmacology 31:1537–1544.
T Ohmori , T Abekawa , T Koyama (1995) Scopolamine prevents the development of sensitization to methamphetamine. Life Sci 56:1223–1229.
N Omelchenko , SR Sesack (2006) Cholinergic axons in the rat ventral tegmental area synapse preferentially onto mesoaccumbens dopamine neurons. J Comp Neurol 494:863–875.
M Perez-Reyes , WR White , SA McDonald , JM Hill , AR Jeffcoat , CE Cook (1991) Clinical effects of methamphetamine vapor inhalation. Life Sci 49:953–959.
JG Plebani , KG Lynch , Q Yu , HM Pettinati , CP O'Brien , KM Kampman (2012) Results of an initial clinical trial of varenicline for the treatment of cocaine dependence. Drug Alcohol Depend 121:163–166.
KS Rau , E Birdsall , JE Hanson , KL Johnson-Davis , FI Carroll , DG Wilkins (2005) Bupropion increases striatal vesicular monoamine transport. Neuropharmacology 49:820–830.
CR Rush , WW Stoops , JA Lile , PE Glaser , LR Hays (2011) Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance. Psychopharmacology 214:665–674.
J Shearer , S Darke , C Rodgers , T Slade , I van Beek , J Lewis (2009) A double-blind, placebo-controlled trial of modafinil (200 mg/day). for methamphetamine dependence. Addiction 104:224–233.
S Shoptaw , KG Heinzerling , E Rotheram-Fuller , T Steward , J Wang , AN Swanson (2008) Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend 96:222–232.
D Siegal , J Erickson , H Varoqui , L Ang , KS Kalasinsky , FJ Peretti (2004) Brain vesicular acetylcholine transporter in human users of drugs of abuse. Synapse 52:223–232.
M Sofuoglu , S Brown , DA Babb , PR Pentel , DK Hatsukami (2000) Carvedilol affects the physiological and behavioral response to smoked cocaine in humans. Drug Alcohol Depend 60:69–76.
K Taguchi , J Atobe , M Kato , T Chuma , T Chikuma , T Shigenaga (1998) The effect of methamphetamine on the release of acetylcholine in the rat striatum. Eur J Pharmacol 360:131–137.
J Tiihonen , K Kuoppasalmi , J Fohr , P Tuomola , O Kuikanmaki , H Vorma (2007) A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. Am J Psychiatry 164:160–162.
ND Volkow , L Chang , GJ Wang , JS Fowler , M Leonido-Yee , D Franceschi (2001) Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 158:377–382.
ND Volkow , GJ Wang , Y Ma , JS Fowler , C Wong , YS Ding (2005) Activation of orbital and medial prefrontal cortex by methylphenidate in cocaine-addicted subjects but not in controls: relevance to addiction. J Neurosci 25:3932–3939.
ND Volkow , JS Fowler , J Logan , D Alexoff , W Zhu , F Telang (2009) Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. JAMA 301:1148–1154.
GJ Wang , L Smith , ND Volkow , F Telang , J Logan , D Tomasi (2012) Decreased dopamine activity predicts relapse in methamphetamine abusers. Mol Psychiatry 17:918–925.